Search Results

For discovery teams, this means a shorter exposure can yield longer efficacy windows—opening doors to Kenakin  will get released next month, featuring real questions from discovery scientists tackling enzyme Join Terry’s Corner and get: Frameworks proven in real discovery programs On-demand lessons  designed That’s why discovery teams turn to Terry’s Corner: to build strategies that anticipate these collisions Kenakin with your own enzyme or GPCR interaction puzzles.

However, in drug discovery projects, perfection can’t be attained soon enough. If only Voltaire were here today to see how drug discovery is being accelerated by new technologies. Several new technologies that are being used to accelerate drug discovery are highlighted in this article receptors (GPCRs) to enable the discovery of agonistic biologics; and automated instrumentation that Read more at the source #DrGPCR #GPCR #IndustryNews

thinking is the enemy of discovery. If you’re building tools or careers in GPCR science, this is your playbook. The pHSense Breakthrough: Two Dimensions of Discovery pHSense wasn’t built in a vacuum—it was born from GPCR   Dr. GPCR X Revvity Collaboration ⸻ Want more like this? 👉 Join the Dr. GPCR Premium Ecosystem  for behind-the-scenes access to GPCR innovators, exclusive deep-dives, and practical

We're zooming back to the future of GPCR discoveries. Discovery and Antibody Innovation: DeciBio Q&A with Sean McClain, Founder & CEO, and Zach Jonasson, Drug Discovery February 15 - 19, 2025 | BPS 2025 February 16 - 21, 2025 | Harnessing the Power of Advanced Multimodal Approaches to GPCR Drug Discovery March 12 - 14, 2025 | NextGen Biomed 2025 March 25 - 28 Discovery Chemistry April 24 - 27, 2025 | American Physiology Summit 2025 April 25 - 30, 2025 | AACR

Eric Trinquet, that moment arrived when his team successfully tracked GPCR internalization in native Just a plate reader, an agonist, and an endogenous GPCR. What started as a chemistry problem has evolved into a discovery platform. GPCR   Dr. GPCR X Revvity Collaboration ⸻ Want more like this? 👉 Join the Dr. GPCR Premium Ecosystem for behind-the-scenes access to GPCR innovators, exclusive deep-dives, and practical

translatome via site-selective activation of mTOR GPCR Binders, Drugs, and more Molecular glues as potential heart failure drug following reverse merger with Avrobio Lilly signs $140M upfront partnership with Webinar - The value of GPCR cell-based assays in drug discovery October 2024 | Biologics US 2024 October Biochemistry, Cellular and Mechanistic Pharmacology; Lead Discovery and Optimization NEW Director/Sr Director GPCR Drug Discovery Biologist HIGHLIGHT Principal Scientist, In vitro pharmacology Post-Doctoral

discovery strategies. GPCR Event Spotlight Discovery on Target’s 19th Annual GPCR-Based Drug Discovery Targeting G Protein-Coupled Register today for the GPCR Drug Discovery Conference and save $200 with discount code “ DRGPCR24 ”. - The value of GPCR cell-based assays in drug discovery September 22, 2024 | Biomolecular Horizons 2024 26 - 28, 2024 | GPCRs-Targeted Drug Discovery Summit Europe July 12 - 17, 2026 | 20th World Congress

as the most important drug targets. Classically, GPCR internalization has been considered to lead to receptor desensitization. new understanding for the receptor internalization, the mechanism of physiology/pathology and novel drug , which will offer new insights into the regulatory mechanism of GPCR signaling and novel drug targets Read more at the source #DrGPCR #GPCR #IndustryNews

GPCR Ecosystem. GPCR Podcast To mark the spotlight, Dr. GPCR  invited Dr. Eric Trinquet  to the Dr. GPCR. GPCR Dr. Its GPCR research tools  support discovery teams and academic labs with precision reagents and validated

October 2022 "Type 2 bradykinin receptor (B2R) is an essential G protein-coupled receptor (GPCR) that provided molecular insights into the functions and regulation of B2R, which shed light on structure-based drug In this review, we summarize the structure and function of B2R in relation to drug discovery and discuss Read more at the source #DrGPCR #GPCR #IndustryNews

drug discovery Nicola J Smith, Lauren T May, and Natasha L Grimsey for their work on Highlights and Binders, Drugs, and more Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Drug Discovery Engine at ENDO 2024 The Promise of Oxytocin: Novel Approaches for Targeting Oxytocin June 4, 2024 | Live Webinar ‘It All Starts With a Protein – Protein Sciences as a Key to Success in Drug Discovery’ June 9 - 14, 2024 | 2024 Phosphorylation and G-Protein Mediated Signaling Networks June 25

function and expression landscape Odorant receptors (ORs) belong to the G protein-coupled receptor (GPCR Exploring ORs in drug discovery – opportunities and threats Given the functional relevance of ORs in (for drug repurposing) and endogenous ligands. discovery. Future directions Important directions in ORs research to advance drug discovery include the deorphanization

GPCR, it was with a simple goal: to connect people who shared a passion for GPCR science and discovery Capital, CRO partners, and GPCR experts to help teams move faster — from idea to discovery — while reducing Consulting Corner — a place for teams to get tailored scientific and strategic guidance that helps bridge discovery courses will be included in Premium Membership , giving members full access to learning, connection, and discovery while strengthening discovery where it truly happens — in the lab.

ligands Elements of a comprehensive and effective GPCR discovery Master advanced applications: Using with real-time kinetics Discovering new ligands and GPCR behaviors for unique drug profiles   GPCR Event breathe new life into schizophrenia pipeline GPCR Dynamics Reveal Mechanisms for Drug Discovery DMS: Discovery Ecosystem Summit Tectonic Therapeutic Announces Closing of Merger with AVROBIO as well as in drug discovery October 2024 | Biologics US 2024   October 2 - 4, 2024 | 9th GPCRs in Medicinal Chemistry

Here’s a sneak peek at what you can expect: Principles of Pharmacology in Drug Discovery I - Techniques Principles of Pharmacology in Drug Discovery II - Advanced Methods for the Optimization of Candidate be exploited for new drug discovery. in drug discovery October 2024 | Biologics US 2024 October 2 - 4, 2024 | 9th GPCRs in Medicinal Chemistry Director GPCR Drug Discovery Biologist Post-Doctoral Scientist- Molecular Pharmacology (FDE) Research

February 2022 Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with discovery. Better known as GPCR, the fruitful research space has led to more than 700 approved drugs over previous with the target and analogizes the search for new drugs to oil drilling around the world." Read more at the source #DrGPCR #GPCR #IndustryNews

highly diverse range of chemical stimuli, they represent the therapeutic targets for many existing drugs GPCRs as environmental sensors; 3. New approaches to GPCR drug discovery. discuss new enabling technologies in order to leverage the recent advances in the field towards new discoveries and solutions in GPCR drug discovery.

How a Collaboration Led to a GPCR Imaging Breakthrough JB didn’t set out to contribute to a GPCR imaging It was the start of a scientific partnership with the potential to shift how GPCRs could be visualized Designing Reliable GPCR Imaging Tools for Real Biological Systems Success brought new challenges. This strategy accelerated discovery and reduced noise, helping them understand how each design change The Future of GPCR Imaging Breakthroughs: AI, Multiplex Tools, and In Vivo Discovery Today, JB leads

GPCR Podcast features a recap of the Endocrine Metabolic GPCRs 2024 with the organizers, Drs. Adhesion GPCR Consortium: The 11th Adhesion GPCR Workshop. Binders, Drugs, and more Structure-based identification of a G protein-biased allosteric modulator of Drug Discovery Platform GPCRs and Emotional Pain: Exploring Non-Narcotic Pathways to Relief GPCR Events GPCR Ecosystem

Hi GPCR Community, If you work on GPCR discovery, you already know: early signals can mislead, and timing Upcoming events:  “Drug Discovery at Superluminal Speeds”; and Discovery on Target 2025—GPCR track you discovery and translational pharmacology. Read the article here ➤ Discovery on Target 2025 – GPCR Speaker Spotlight DOT 2025 (Sept 22–25, Boston GPCR scientists, translational pharmacologists, biotech discovery teams, platform company leaders, and

Portfolio with Granted Patents in Australia and Singapore Crinetics Announces FDA Acceptance of New Drug Drug Discovery February 15 - 19, 2025 | BPS 2025 February 16 - 21, 2025 | Harnessing the Power of Advanced Multimodal Approaches to GPCR Drug Discovery March 12 - 14, 2025 | NextGen Biomed 2025 March 25 - 28 Discovery Chemistry April 24 - 27, 2025 | American Physiology Summit 2025 April 25 - 30, 2025 | AACR for programmable sensing and control of cell behaviour GPCR Binders, Drugs, and more Exploring potential

discovery.” GPCR’s global network, educational content, and discovery tools, visit  ecosystem.drgpcr.com . ______ GPCR empowers scientists and companies advancing receptor biology and drug discovery. a biotech company based in Spain that specializes in the development of optimal chemical tools for drug discovery.

Interdisciplinary design isn’t optional in GPCR imaging. It’s the catalyst. discovery — the instant where the experiment stops being data and starts being meaning. And the most striking validation came from in vivo GPCR imaging. Strong GPCR imaging tools come from strong interdisciplinary relationships.  🎧 Listen to the full episode https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/chemical-probes-for-gpcr-imaging-and-internalization

Drug discovery does not move in fixed conclusions. discovery efforts. Drug Discovery Programs Pharmacologists know the pressure of distinguishing between orthosteric and discovery pipelines Operationalizing Allosteric Signatures Early workflows often rely on rapid “one-way GPCR systems are sensitive and context-dependent.

Brian Shoichet, Bryan Roth, et al. for their research on AlphaFold2 structures guide prospective ligand discovery ADGRG6/GPR126 is a key regulator of receptor signaling GPCR Binders, Drugs, and more Silicon-Rhodamine Prototypic G Protein-Coupled Adenosine A2A Receptor AlphaFold2 structures guide prospective ligand discovery Drug Discovery Engine at ENDO 2024 𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐢𝐧𝐠 𝐀𝐋𝐋𝐎𝐃𝐃: 𝐀𝐥𝐥𝐨𝐬𝐭𝐞𝐫𝐲 𝐢𝐧 𝐃𝐫𝐮𝐠 Discovery’ June 9 - 14, 2024 | 2024 Phosphorylation and G-Protein Mediated Signaling Networks June 25

GPCR Virtual Cafe. This time with none other than Dr. https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe/ #gpcr #drgpcr #virtualcafe

GPCR University We're thrilled to share that all spots for the Applying Pharmacology to Drug Discovery GPCR Partnered Events 3rd GPCRs - Targeted Drug Discovery Summit  Join us at the 3rd GPCRs Targeted Drug Discovery Summit in Boston on March 5-7, 2024. localization GPCR Binders, Drugs, and more Decrypting orphan GPCR drug discovery via multitask learning Discovery Chemistry April 4 - 7, 2024 | American Physiology Summit April 5 - 10, 2024 | AACR Annual

Binders, Drugs, and more Altered G-Protein Transduction Protein Gene Expression in the Testis of Infertile , and more Key Aspects of Modern GPCR Drug Discovery Location bias: A "Hidden Variable" in GPCR pharmacology Discovery Engine and Pipeline of Small Molecule Therapeutics Reproducibility of Tanso Biosciences' GPCR September 7 - 8, 2023 | 3rd Transatlantic ECI GPCR Symposium September 25 - 28, 2023 | Discovery On Target September 27 - 28, 2023 | Training Seminar "The Renaissance in GPCRs as Drug Targets: Allosteric

October 2022 Identification of A2BAR as a potential target in colorectal cancer using novel fluorescent GPCR ligands "G-protein coupled receptors (GPCRs) have been largely targeted in a wide range of diseases, but few therapies have been directed against GPCRs in the field of cancer, partly because of the lack imaging, and as possible new tools used for target validation in drug screening methodologies." Read more at the source #DrGPCR #GPCR #IndustryNews

August 2022 "GPCRs modulate a plethora of physiological processes and mediate the effects of one-third of FDA-approved drugs. Ligands eliciting biased signalling may constitute better drugs with higher efficacy and fewer adverse The guidelines will aid consistency and clarity, as the basic receptor research and drug discovery communities Read more at the source #DrGPCR #GPCR #IndustryNews